Anticancer effect of a lentiviral vector capable of expressing HIV-1 Vpr

Clinical Cancer Research

Volumn 7, Issue 11, 2001, Pages 3567-3573

  Pang, Shen ^a,b   Kang, Mo K ^a,b   Kung, Sam ^c   Yu, Duan ^a,b   Lee, Annie ^a,b   Poon, Betty ^c   Chen, Irvin S Y ^c   Lindemann, Bob ^a   Park, No Hee ^a,b  

^a School of Dentistry   (United States)

^b Dental Research Institute   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR; VPR PROTEIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IN VIVO STUDY; LENTIVIRINAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TUMOR; TUMOR VOLUME; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; GENE EXPRESSION; GENE PRODUCTS, VPR; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV-1; IMMUNOCOMPROMISED HOST; LENTIVIRUS; LUMINESCENT PROTEINS; MICE; MICE, INBRED C3H; MICE, NUDE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035181481     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Transfer of genes to humans: Early lessons and obstacles to success
2. Gene therapy-promise pitfalls, and prognosis
3. The promise of gene therapy within reach?
4. Gene therapy for oral cancer: Recent progress in research
5. Nonrandom chromosome aberrations and clonal populations in head and neck cancer
6. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: A retrospective review of the literature
7. Molecular changes in oral cancer may reflect aetiology and ethnic origin
8. Cell death and cancer: Replacement of apoptotic genes and inactivation of death suppressor genes in therapy
9. Mechanisms of p53-mediated apoptosis
10. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
11. Cure of colon cancer metastasis in rats with the new lipid A OM 174. Apoptosis of tumor cells and immunization of rats
12. A naturally immunogenic virion-associated protein specific for HIV-2 and SIV
13. Human immunodeficiency virus vpr product is a virion-associated regulatory protein
14. The HIV-1 Vpr protein influences nuclear targeting of viral nucleic acids in non-dividing cells
15. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM)
16. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle
17. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection
18. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest
19. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
20. Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard
21. Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells
22. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
23. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
24. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents
25. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
26. A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes
27. Lentivirus-based vectors transduce mouse hematopoietic stem cells with similar efficiency to moloney murine leukemia virus-based vectors
28. Lentiviral vectors: Turning a deadly foe into a therapeutic agent
29. A murine model for the immunotherapy of head and neck squamous cell carcinoma
30. Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma
31. Gene therapy for cancer
32. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: A liposome-mediated gene therapy treatment for bladder cancer
33. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: Molecular and clinical pharmacology
34. Immunotherapy of head and neck cancer
35. Cancer gene and immunotherapy: Recent developments
36. Function and dysfunction of CD4(+) T cells in the immune response to melanoma
37. Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines
38. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
39. Development of a self-inactivating lentivirus vector
40. Regulation of gene expression by human foamy virus and potentials of foamy viral vectors